Epigenetic Tumor Markers in Plasma and Serum

This publication has 55 references indexed in Scilit:

• Tumor‐Derived Epigenetic Changes in the Plasma and Serum of Liver Cancer Patients: Implications for Cancer Detection and Monitoring
  Annals of the New York Academy of Sciences, 2000
• Aberrant p15 promoter methylation in adult and childhood acute leukemias of nearly all morphologic subtypes: potential prognostic implications
  Blood, 2000
• Molecular Detection of Tumor Cells in Bronchoalveolar Lavage Fluid From Patients With Early Stage Lung Cancer
  JNCI Journal of the National Cancer Institute, 1999
• Aberrant methylation of p16 ^INK4a is an early event in lung cancer and a potential biomarker for early diagnosis
  Proceedings of the National Academy of Sciences, 1998
• K-ras mutations are found in DNA extracted from the plasma of patients with colorectal cancer
  Gastroenterology, 1997
• Microsatellite alterations in plasma DNA of small cell lung cancer patients
  Nature Medicine, 1996
• Inactivation of multiple tumor-suppressor genes involved in negative regulation of the cell cycle, MTS1/p16INK4A/CDKN2, MTS2/p15INK4B, p53, and Rb genes in primary lymphoid malignancies
  Blood, 1996
• Analysis of a family of cyclin-dependent kinase inhibitors: p15/MTS2/INK4B, p16/MTS1/INK4A, and p18 genes in acute lymphoblastic leukemia of childhood
  Blood, 1995
• Point mutations of the N‐ras gene in the blood plasma DNA of patients with myelodysplastic syndrome or acute myelogenous leukaemia
  British Journal of Haematology, 1994
• Functional interactions of the retinoblastoma protein with mammalian D-type cyclins
  Cell, 1993